William Blair stays Outperform on Viking Therapeutic (VKTX) amid 'torrid pace' in advancing VK2735

Go back to William Blair stays Outperform on Viking Therapeutic (VKTX) amid 'torrid pace' in advancing VK2735
ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) Delayed: 32.50 +2.12 (6.98%)
Previous Close $30.38    52 Week High $5.17 
Open $30.52    52 Week Low $0.94 
Day High $32.90    P/E N/A 
Day Low $30.52    EPS $0.00 
Volume 2,055,608